CAMBRIDGE, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CONVERGENT RESEARCH INC, founded in 2022, is a mid-sized nonprofit in the Science & Technology sector that reported $72.4M in total revenue in fiscal year 2024. Revenue fell 28% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $24.9M, a strong 34% operating margin.
THE ORGANIZATION IS A DELAWARE NON-PROFIT, NON-STOCK CORPORATION FORMED EXCLUSIVELY FOR CHARITABLE, EDUCATIONAL AND SCIENTIFIC PURPOSES. IN FURTHERANCE OF SUCH PURPOSES, THE ORGANIZATION WILL FOSTER, SUPPORT, PROMOTE, AND CONDUCT PROGRAMS, PROJECTS, AND ACTIVITIES DESIGNED TO DEVELOP AND ACCELERATE SCIENTIFIC AND TECHNOLOGICAL RESEARCH AND INNOVATION IN THE PUBLIC INTEREST, INCLUDING, WITHOUT LIMITATION, THROUGH INCUBATING RESEARCH PROJECTS AND FACILITATING COLLABORATIONS TO BUILD ESSENTIAL RESEARCH TOOLS AND RESOURCES THAT CAN BE DEPLOYED BROADLY FOR THE PUBLIC BENEFIT.
RESEARCH: SUPPORTED SCIENTISTS, ENGINEERS, AND RESEARCHERS IN FOCUSED RESEARCH ORGANIZATIONS (FROS) DEDICATED TO THE ADVANCEMENT OF SCIENCE AND TECHNOLOGY; SUPPORTED SCIENTIFIC AND TECHNOLOGICAL...
RESEARCH: SUPPORTED SCIENTISTS, ENGINEERS, AND RESEARCHERS IN FOCUSED RESEARCH ORGANIZATIONS (FROS) DEDICATED TO THE ADVANCEMENT OF SCIENCE AND TECHNOLOGY; SUPPORTED SCIENTIFIC AND TECHNOLOGICAL ANALYSIS CAPABILITIES SUCH AS MICROSCOPY AND DNA SEQUENCING, BRAIN CIRCUIT MAPPING, OCEAN BASED CARBON DIOXIDE REMOVAL, AND OTHER EQUIPMENT TO SUPPORT FRO ADVANCEMENTS; PROVIDED LABORATORY AND OFFICE SPACE FOR FROS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $72,426,908 | $100,177,078 | -0.3% |
| Expenses | $47,527,392 | $30,152,575 | +0.6% |
| Net Income | $24,899,516 | $70,024,503 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| TOM KALIL | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MEGAN BLEWETT | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| CHERYL MARTIN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MORGAN LEVINE | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| RICHARD MURRAY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ADAM MARBLESTONE | CHIEF EXECUTIVE OFFICER | 40.00 |
Officer
|
$431,025 | $55,316 | $486,341 |
| ANASTASIA GAMICK | CHIEF OPERATING OFFICER | 40.00 |
Officer
|
$360,495 | $28,670 | $389,165 |
| WILLIAM BIEDERMAN | CTO - FOREST NEUROTECH | 40.00 |
Highest
|
$472,269 | $52,311 | $524,580 |
| HENRY LEE | CEO - CULTIVARIUM | 40.00 |
Highest
|
$342,180 | $19,247 | $361,427 |
| WILLIAM BUSA | CEO - EVE BIO | 40.00 |
Highest
|
$339,475 | $43,590 | $383,065 |
| TYSON AFLALO | CSO - FOREST NEUROTECH | 40.00 |
Highest
|
$330,062 | $14,041 | $344,103 |
| DAVID LANSKY | GENERAL COUNSEL | 40.00 |
Highest
|
$407,323 | $35,205 | $442,528 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $72,426,908 | $47,527,392 | $108,005,415 | $24,899,516 |
| 2023 | $100,177,078 | $30,152,575 | $85,511,113 | $70,024,503 |
| 2022 | $11,258,027 | $6,496,686 | $9,047,793 | $4,761,341 |
Compare CONVERGENT RESEARCH INC with other nonprofits in Massachusetts and across the country.